| 1 |
29458405 | Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo. | 2018 Feb 20 |
1 |
| 2 |
30109181 | Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo. | 2018 Jul |
1 |
| 3 |
30114704 | PCI29732, a Bruton's Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells. | 2018 |
1 |
| 4 |
28303028 | Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo. | 2017 Mar 17 |
1 |
| 5 |
25829763 | The enriched fraction of Elephantopus scaber Triggers apoptosis and inhibits multi-drug resistance transporters in human epithelial cancer cells. | 2015 Apr-Jun |
2 |
| 6 |
15807535 | N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane. | 2005 Apr 12 |
1 |
| 7 |
12374800 | Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation. | 2002 Dec 13 |
1 |
| 8 |
11559526 | Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. | 2001 Sep 15 |
3 |